Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...

The European Commission approved Pfizer's respiratory syncytial virus vaccine for the prevention of lower respiratory tract ...

In this role, Kulkarni will drive the agency’s strategic expansion, strengthen its market position, and spearhead its next ...

Pharma stocks just got a new risk factorand it's not a new drug trial. President Trump is preparing to slap tariffs on ...

Major drugmakers were trading sharply lower on Tuesday as Wall Street is bracing for a broader set of tariffs that President ...

Millions of households are bracing themselves for a raft of price increases across a range of bills – from energy and water ...

London open The FTSE 100 is expected to open 42 points higher on Tuesday, having closed down 0.88% on Monday at 8,582.81.

Long-standing trade agreements have largely sheltered the pharmaceutical industry from tariffs but President Donald Trump's ...

Trump's Liberation Day tariff plans spare pharmaceuticals for now, with Big Pharma lobbying for gradual measures. Read more ...

The global canine flu therapeutics market is set for substantial growth, with projections estimating a market value of USD 3.06 billion by 2033. The market, which was valued at USD 2.04 billion in ...